Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOLUTEGRAVIR Cause Rash maculo-papular? 29 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Rash maculo-papular have been filed in association with DOLUTEGRAVIR (Juluca). This represents 0.3% of all adverse event reports for DOLUTEGRAVIR.

29
Reports of Rash maculo-papular with DOLUTEGRAVIR
0.3%
of all DOLUTEGRAVIR reports
1
Deaths
20
Hospitalizations

How Dangerous Is Rash maculo-papular From DOLUTEGRAVIR?

Of the 29 reports, 1 (3.4%) resulted in death, 20 (69.0%) required hospitalization, and 1 (3.4%) were considered life-threatening.

Is Rash maculo-papular Listed in the Official Label?

Yes, Rash maculo-papular is listed as a known adverse reaction in the official FDA drug label for DOLUTEGRAVIR.

What Other Side Effects Does DOLUTEGRAVIR Cause?

Foetal exposure during pregnancy (1,036) Exposure during pregnancy (776) Virologic failure (770) Pathogen resistance (586) Maternal exposure during pregnancy (517) Viral mutation identified (510) Treatment failure (453) Drug ineffective (447) Off label use (413) Blood hiv rna increased (410)

What Other Drugs Cause Rash maculo-papular?

SULFAMETHOXAZOLE\TRIMETHOPRIM (935) AMOXICILLIN (871) VANCOMYCIN (642) PIPERACILLIN\TAZOBACTAM (629) PANTOPRAZOLE (589) LAMOTRIGINE (568) ALLOPURINOL (550) CARBOPLATIN (529) ACETAMINOPHEN (499) CLINDAMYCIN (484)

Which DOLUTEGRAVIR Alternatives Have Lower Rash maculo-papular Risk?

DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL DOLUTEGRAVIR vs DOLUTEGRAVIR\RILPIVIRINE DOLUTEGRAVIR vs DOMPERIDONE DOLUTEGRAVIR vs DOMPERIDONE\PANTOPRAZOLE

Related Pages

DOLUTEGRAVIR Full Profile All Rash maculo-papular Reports All Drugs Causing Rash maculo-papular DOLUTEGRAVIR Demographics